Increased apoptosis is implicated in several other diabetic complications such as neuronial apoptosis in neuropathy, cardiomyocyte apoptosis in cardiomyopathy, and mesangial cell apoptosis in nephropathy. Diabetes can affect capillaries[19], neurons, and glia[19] within the retina and alters the function and structure of all retinal cell types. Much evidence had shown the apoptosis in the ganglion cells layer, the inner nuclear layers[20], and photoreceptors and microvascular cells[19] in diabetic retina. Direct diabetes damage to glial cell or neuronal metabolism would directly impact neurotransmission[21] and may lead to apoptosis of retinal neurons and visual field defects. Indeed, retinal axons are lost before the onset of visible vascular lesions[22]. Recent reports also demonstrate that impaired local responses on the multifocal electroretinograms predict subsequent development of vascular lesions[23]. Vision depends on neuronal function, so most forms of vision impairment with clear ocular media must include neuronal dysfunction definitely. Further work is needed to determine how alterations in ganglion, glial, microglial, and neuronal cell interactions reduce the quality of vision.
CTGF is a cysteinerich matricellular protein belonging to the CCN family of proteins, which have many diverse functions such as angiogenesis, fibrosis and apoptosis and so on. Recently, various studies have shown that CTGF expression at the mRNA or protein level in retina has previously been demonstrated in vivo in diabetic rat[24] and human[25], as well as in cultured retinal microvascular cells[26]. CTGF has been shown to be upregulated in the retina together with endothelial cell death. These are believed to be the result of metabolic changes caused by hyperglycemia and advanced glycation end products (AGEs)[27]. Overexpression of CTGF in cultured human aortic smooth muscle cells, a cell type closely related to pericytes and mesangial cells induces apoptosis by activating caspase 3[28]. Moreover, the involvement of Cyr61 and CTGF in pericyte detachment and anoikis was implicated in the pathogenesis of DR[29]. Cyr61 and CTGFinduced apoptosis was mediated through the intrinsic pathway and involved the expression of genes that have been functionally grouped as p53 target genes. Expression of the matrix metalloproteinase2 gene, a known target of p53, was increased in pericytes overexpressing either Cyr61 or CTGF. Inhibition of matrix metalloproteinase2 had, at least in part, a protective effect against Cyr61 and CTGFinduced apoptosis.
Thus, it is possible that upregulation of CTGF may contribute to inducing apoptosis, especially in the vascular endothelium cells, ganglion cells, perhaps included the glial cells. This upregulation leads to the loss of retinal cells as a critical early event. And then the vascular cells affected suggest that cell loss may be a direct result of a consequence of widespread vascular disease in the etiology of diabetic retinopathy[30]. But Alistair J et al indicated that most of the apoptotic cells in the retina are not endothelial cells or pericytes. Judging from such different findings, there might be an unidentified mechanism modulating the apoptosis in the diabetic retina.
Together, these studies leave little doubt that apoptosis is the earliest detectable changes in diabetes. Regardless of whether the initial events begin in blood vessels or neural cells, the clinical stage of diabetic retinopathy manifest cellular, histological, and functional features of a retinal neuropathy[31]. To the best of our knowledge, there is no evidence that a primary, selective defect in vascular cells is sufficient to cause diabetic retinopathy. Clearly, it is essential to treat both the vascular and neural elements of the retina to preserve vision. This concept permits a new paradigm for understanding the mechanism of vision impairment in diabetes and provides therapeutic targets that are directly linked to vision[32,33]. In summary, this study suggests that CTGF may be involved in apoptosis which is a characteristic of early diabetic retina. siRNA targeting CTGF seems to have the advantage of ameliorating retina apoptosis directly or indirectly. This study provides evidence treatment strategies that intravitreous injection of siRNA containing potentially therapeutic transgenes treatment[34,35]. However, it remains unclear how upregulated expression of CTGF in the diabetic retina and the exact mechanism leading to apoptosis in STZ rats should be further investigated. Meanwhile, we must be cautious in interpreting these findings, because animal models of diabetic retinopathy do not exhibit advanced retinal lesions such as those seen in the man.
【参考文献】
1 Abu ElAsrar AM, Dralands L, Missotten L, AlJadaan IA, Geboes K. Expression of apoptosis markers in retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci 2004;45(8):27602766
2 Hudson BI, Schmidt AM. RAGE: a novel target for drug intervention in diabetic vascular disease. Pharm Res 2004;21(7):1079 1086
3 Barile GR, Pachydaki SI, Tari SR , Lee SE, Donmoyer CM, Ma W, Rong LL, Buciarelli LG, Wendt T, H rig H, Hudson BI, Qu W, Weinberg AD, Yan SF, Schmidt AM. The RAGE axis in early diabetic retinopathy. Invest Ophthalmol Vis Sci 2005;46(8):29162924
4 Caldwell RB, Bartoli M, Behzadian MA ElrRemessy AE, AlShabrawey M, Platt DH, Liou GI, Caldwell RW. Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. Curr Drug
Targets 2005;6(4):511524
5 Kita T, Hata Y, Kano K, Miura M, Narkao S, Noda Y, Shimokawa H, Ishibashi T. Transforming Growth Factor 2 and Connective Tissue Growth Factor in Proliferative Vitreoretinal Diseases, Possible Involvement of Hyalocytes and Therapeutic Potential of Rho Kinase Inhibitor. Diabetes 2007;56(1):231238
6 Park SH, Park JW, Park SJ, Kim KY, Chung JW, Chun MH, Oh SJ. Apoptotic death of photoreceptors in the streptozotocininduced diabetic rat retina. Diabetologia 2003(9);46:12601268
7 Barber AJ, Antonetti DA, Gardner TW. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes: the Penn State Retina Research Group. Invest Ophthalmol Vis Sci 2000(1);41:35613568
8 Behl Y, Krothapalli P, Desta T, DiPiazza A, Roy S, Graves DT. DiabetesEnhanced Tumor Necrosis Factorα Production Promotes Apoptosis and the Loss of Retinal Microvascular Cells in Type 1 and Type 2 Models of Diabetic Retinopathy. American Journal of Pathology 2008;172(5):14111418
9 Park SH, Park JW, Park SJ, Kim KY, Chung JW, Chun MH, Oh SJ. Apoptotic death of photoreceptors in the streptozotocininduced diabetic rat retina. Diabetologia 2003;46(9):12601268
10 Krady JK, Basu A, Allen CM, Xu Y, LaNoue KF, Gardner TW, Levison SW. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase3 activation in a rodent model of diabetic retinopathy. Diabetes 2005;54(5):15591565
11 Liu H, Yang R , Tinner B, Choudhry A, Schutze N, Chaqour B. Cysteinerich protein 61 and connective tissue growth factor induce deadhesion and anoikis of retinal pericytes. Endocrinology 2008;149(4):16661677
12 Van Setten G, Berglin L, Blalock TD , Schultz G.. Detection of connective tissue growth factor in subretinal fluid following retinal detachment: possible contribution to subretinal scar formation, preliminary results. Ophthalmic Res 2005;37(6):289292
13 Zhou XD, Xiong MM, Tan FK, Guo XJ, Arnett FC. SPARC, An upstream regulator of connective tissue growth factor in response to transforming growth factor β stimulation. Arthritis & Rheumatism 2006;54(12):38853889
上一页 [1] [2] [3] 下一页 |